Keratoacanthoma (KA): An update and review

Journal of the American Academy of Dermatology

Volumn 74, Issue 6, 2016, Pages 1220-1233

  Kwiek, Bartlomiej ^a   Schwartz, Robert A ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

BRAF inhibitor; erlotinib; Ferguson Smith; Grzybowski; histopathology; keratoacanthoma; multiple keratoacanthoma; multiple self healing squamous epithelioma; squamous cell carcinoma; treatment

Indexed keywords

BLEOMYCIN; FLUOROURACIL; INTERFERON; METHOTREXATE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; WNT PROTEIN; B RAF KINASE; PROTEIN KINASE INHIBITOR;

AMELANOTIC MELANOMA; CELL DIFFERENTIATION; CHEMOTHERAPY; CLINICAL FEATURE; CONJUNCTIVA; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DNA REPAIR; EPILUMINESCENCE MICROSCOPY; EPITHELIUM TUMOR; EXCISION; FOLLOW UP; GENETIC BACKGROUND; GENETIC DISORDER; GENETIC PREDISPOSITION; HAIR; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; INCONTINENTIA PIGMENTI; INTRALESIONAL DRUG ADMINISTRATION; KERATOACANTHOMA; MONOTHERAPY; NEURODERMATITIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; REVIEW; SKIN BIOPSY; TUMOR RECURRENCE; WNT SIGNALING PATHWAY; X RAY; XERODERMA PIGMENTOSUM; ANTAGONISTS AND INHIBITORS; METABOLISM; PATHOLOGY; SKIN DISEASES;

DERMOSCOPY; HUMANS; KERATOACANTHOMA; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; SKIN DISEASES; WNT SIGNALING PATHWAY;

EID: 84957063643     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2015.11.033     Document Type: Review

References (175)

1. J. Hutchinson Morbid growths and tumors: 1: the "crateriform ulcer of the face" a form of acute epithelial cancer Trans Pathol Soc London 40 1889 275 281
2. J. Hutchinson A peculiar form of cancer of the skin: illustrations of clinical surgery consisting of plates, photographs, woodcuts, diagrams, etc. illustrating surgical diseases, symptoms and accidents also operative and other methods of treatment with descriptive letterpress Vol 1 1888 P Blakiston and Son Philadelphia (PA) Plate 92
3. R.A. Schwartz Keratoacanthoma: a clinico-pathologic enigma Dermatol Surg 30 2004 326 333
4. R.A. Schwartz Keratoacanthoma J Am Acad Dermatol 30 1994 1 19 quiz 20-22
5. J.C. Mandrell, and D. Santa Cruz Keratoacanthoma: hyperplasia, benign neoplasm, or a type of squamous cell carcinoma? Semin Diagn Pathol 26 2009 150 163
6. R.A. Carr, and J.P. Houghton Histopathologists' approach to keratoacanthoma: a multisite survey of regional variation in Great Britain and Ireland J Clin Pathol 67 2014 637 638
7. J.J. Sullivan Keratoacanthoma: the Australian experience Australas J Dermatol 38 Suppl 1 1997 S36 S39
8. G.T. Reizner, T.Y. Chuang, D.J. Elpern, J.L. Stone, and E.R. Farmer Basal cell carcinoma and keratoacanthoma in Hawaiians: an incidence report J Am Acad Dermatol 29 1993 780 782
9. I.J. Vergilis-Kalner, Y. Kriseman, and L.H. Goldberg Keratoacanthomas: overview and comparison between Houston and Minneapolis experiences J Drugs Dermatol 9 2010 117 121
10. N. Misago, T. Inoue, K. Nagase, and et al. Crater/ulcerated form of infundibular squamous cell carcinoma: a possible distinct entity as a malignant (or high-grade) counterpart to keratoacanthoma J Dermatol 42 2015 667 673
11. C.G. Ramselaar, E.J. Ruitenberg, and W. Kruizinga Regression of induced keratoacanthomas in anagen (hair growth phase) skin grafts in mice Cancer Res 40 1980 1668 1673
12. B. Iyengar, and V. Ramesh Hair cycle and the histogenesis of pillar tumors Indian J Cancer 26 1989 1 9
13. G. Zito, I. Saotome, Z. Liu, and et al. Spontaneous tumor regression in keratoacanthomas is driven by Wnt/retinoic acid signaling cross-talk Nat Commun 5 2014 3543
14. E.L. Lain, and R.F. Markus Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine J Drugs Dermatol 3 2004 680 682
15. B.K. Walder, M.R. Robertson, and D. Jeremy Skin cancer and immunosuppression Lancet 2 1971 1282 1283
16. Y. Kambayashi, T. Fujimura, and S. Aiba Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinoma Acta Derm Venereol 93 2013 663 668
17. R.T. Prehn The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma Cancer Res 56 1996 937 940
18. W. Hu, T. Cook, C.W. Oh, and N.S. Penneys Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma J Am Acad Dermatol 42 2000 473 475
19. M. Corominas, H. Kamino, J. Leon, and A. Pellicer Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation? Proc Natl Acad Sci U S A 86 1989 6372 6376
20. S. Aasi, R. Silkiss, J.Y. Tang, and et al. New onset of keratoacanthomas after vismodegib treatment for locally advanced basal cell carcinomas: a report of 2 cases JAMA Dermatol 149 2013 242 243
21. F. Su, A. Viros, C. Milagre, and et al. RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors N Engl J Med 366 2012 207 215
22. I. Zalaudek, E. Bonifazi, G. Ferrara, and G. Argenziano Keratoacanthomas and Spitz tumors: are they both 'self-limiting' variants of malignant cutaneous neoplasms? Dermatology 219 2009 3 6
23. B. Cribier, Y. Scrivener, and E. Grosshans Tumors arising in nevus sebaceus: a study of 596 cases J Am Acad Dermatol 42 2000 263 268
24. G.V. Long, U. Trefzer, M.A. Davies, and et al. Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicenter, open-label, phase 2 trial Lancet Oncol 13 2012 1087 1095
25. P.B. Chapman, A. Hauschild, C. Robert, and et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
26. R.A. Schwartz, and D.P. Torre The Muir-Torre syndrome: a 25-year retrospect J Am Acad Dermatol 33 1995 90 104
27. R.A. Schwartz The keratoacanthoma: a review J Surg Oncol 12 1979 305 317
28. D.R. Goudie, M. D'Alessandro, B. Merriman, and et al. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1 Nat Genet 43 2011 365 369
29. H.C. Kang, D.A. Quigley, I.J. Kim, and et al. Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology J Invest Dermatol 133 2013 1907 1910
30. R.G. Dufresne, G.M. Marrero, and L. Robinson-Bostom Seasonal presentation of keratoacanthomas in Rhode Island Br J Dermatol 136 1997 227 229
31. C.M. Wolfe, W.H. Green, A.B. Cognetta Jr.; and H.K. Hatfield Multiple squamous cell carcinomas and eruptive keratoacanthomas in an arc welder Dermatol Surg 39 2013 328 330
32. B. Sina, and R.M. Adrian Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemotherapy J Am Acad Dermatol 9 1983 686 688
33. K.J. Craddock, J. Rao, G.J. Lauzon, and V.A. Tron Multiple keratoacanthomas arising post-UVB therapy J Cutan Med Surg 8 2004 239 243
34. V. Brazzelli, T. Barbagallo, F. Prestinari, and et al. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy Photodermatol Photoimmunol Photomed 22 2006 211 213
35. S.J. Robertson, S.J. Bashir, G. Pichert, A. Robson, and S. Whittaker Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin Clin Exp Dermatol 35 2010 e100 e102
36. J.C. Shaw, F.J. Storrs, and E. Everts Multiple keratoacanthomas after megavoltage radiation therapy J Am Acad Dermatol 23 1990 1009 1011
37. S.F. Pattee, and N.G. Silvis Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature J Am Acad Dermatol 48 Suppl 2003 S35 S38
38. B. Mohr III, M.P. Fernandez, and J. Krejci-Manwaring Eruptive keratoacanthomas after Jessners and trichloroacetic acid peel for actinic keratosis Dermatol Surg 39 2013 331 333
39. S. Cox Rapid development of keratoacanthomas after a body peel Dermatol Surg 29 2003 201 203
40. A.J. Mamelak, L.H. Goldberg, D. Marquez, G.A. Hosler, M.R. Hinckley, and P.M. Friedman Eruptive keratoacanthomas on the legs after fractional photothermolysis: report of two cases Dermatol Surg 35 2009 513 518
41. L.H. Goldberg, S. Silapunt, K.K. Beyrau, S.R. Peterson, P.M. Friedman, and M. Alam Keratoacanthoma as a postoperative complication of skin cancer excision J Am Acad Dermatol 50 2004 753 758
42. A. Gewirtzman, D.H. Meirson, and H. Rabinovitz Eruptive keratoacanthomas following carbon dioxide laser resurfacing Dermatol Surg 25 1999 666 668
43. F.N. Ghadially, B.W. Barton, and D.F. Kerridge The etiology of keratoacanthoma Cancer 16 1963 603 611
44. F. Miedzinski, and J. Kozakiewicz Keratoacanthoma centrifugum-a special variety of keratoacanthoma [in German] Hautarzt 13 1962 348 352
45. F. Ozkan, R. Bilgic, and S. Cesur Vulvar keratoacanthoma APMIS 114 2006 562 565
46. G. D'Agostino, and M. Colonna Keratoacanthoma of the vulva [in Italian] Gazz Int Med Chir 67 1962 1032 1038
47. J.A. Svirsky, P.D. Freedman, and H. Lumerman Solitary intraoral keratoacanthoma Oral Surg Oral Med Oral Pathol 43 1977 116 122
48. L.M. Hamed, F.M. Wilson II, and M. Grayson Keratoacanthoma of the limbus Ophthalmic Surg 19 1988 267 270
49. L.R. Eversole, A.S. Leider, and G. Alexander Intraoral and labial keratoacanthoma Oral Surg Oral Med Oral Pathol 54 1982 663 667
50. I. Drizhal, and Z. Nozicka Keratoacanthoma of mucous membrane. A case report Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 16 1973 151 154
51. C. Perrin Tumors of the nail unit. A review. Part II: acquired localized longitudinal pachyonychia and masked nail tumors Am J Dermatopathol 35 2013 693 709 quiz 10-12
52. J.C. Lamp, J.H. Graham, F. Urbach, and C.F. Burgoon Jr. Keratoacanthoma of the subungual region. A clinicopathological and therapeutic study J Bone Joint Surg Am 46 1964 1721 1731
53. B.E. Chaser, K.M. Renszel, A.N. Crowson, and et al. Onycholemmal carcinoma: a morphologic comparison of 6 reported cases J Am Acad Dermatol 68 2013 290 295
54. R.A. Schwartz Multiple persistent keratoacanthomas Oncology 36 1979 281 285
55. A.K. Divers, D. Correale, and J.B. Lee Keratoacanthoma centrifugum marginatum: a diagnostic and therapeutic challenge Cutis 73 2004 257 262
56. A. Khaled, M. Kourda, B. Fazaa, R. Zermani, and M.R. Kamoun Multiple keratoacanthoma centrifugum marginatum Dermatol Online J 16 2010 16
57. Y. Ogasawara, E. Kinoshita, T. Ishida, Y. Hamamoto, J. Fujiyama, and M. Muto A case of multiple keratoacanthoma centrifugum marginatum: response to oral etretinate J Am Acad Dermatol 48 2003 282 285
58. T.P. Wu, K. Miller, D.E. Cohen, and J.A. Stein Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin J Am Acad Dermatol 69 2013 426 430
59. J. Ferguson Smith A case of multiple primary squamous-celled carcinomata of the skin in a young man, with spontaneous healing Br J Dermatol Syphil 46 1934 267 272
60. M.A. Ferguson-Smith, D.C. Wallace, Z.H. James, and J.H. Renwick Multiple self-healing squamous epithelioma Birth Defects Orig Artic Ser 7 1971 157 163
61. C.L. Anzalone, and P.R. Cohen Generalized eruptive keratoacanthomas of Grzybowski Int J Dermatol 53 2014 131 136
62. R.A. Schwartz, M. Blaszczyk, and S. Jablonska Generalized eruptive keratoacanthoma of Grzybowski: follow-up of the original description and 50-year retrospect Dermatology 205 2002 348 352
63. M. Grzybowski A case of peculiar generalized epithelial tumors of the skin Br J Dermatol Syphil 62 1950 310 313
64. A. Nofal, M. Assaf, E. Nofal, and M. Alradi Generalized eruptive keratoacanthoma: proposed diagnostic criteria and therapeutic evaluation J Eur Acad Dermatol Venereol 28 2014 397 404
65. M. Agarwal, R. Chander, S. Karmakar, and R. Walia Multiple familial keratoacanthoma of Witten and Zak - a report of three siblings Dermatology 198 1999 396 399
66. V.H. Witten, and F.G. Zak Multiple, primary, self-healing prickle-cell epithelioma of the skin Cancer 5 1952 539 550
67. B. Boateng, O.P. Hornstein, P. von den Driesch, and F. Kiesewetter Multiple keratoacanthomas (Witten-Zak type) in prurigo simplex subacuta [in German] Hautarzt 46 1995 114 117
68. C.M. Montes, J.C. Maize, and M.L. Guerry-Force Incontinentia pigmenti with painful subungual tumors: a two-generation study J Am Acad Dermatol 50 Suppl 2004 S45 S52
69. A.C. Esser, A. Abril, S. Fayne, and J.A. Doyle Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab J Am Acad Dermatol 50 Suppl 2004 S75 S77
70. R.M. Anforth, T.C. Blumetti, R.F. Kefford, and et al. Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma Br J Dermatol 167 2012 1153 1160
71. R. Gamo, F. Pinedo, J. Vicente, and et al. Keratoacanthoma-like reaction after a hyaluronic acid and acrylic hydrogel cosmetic filler Dermatol Surg 34 2008 954 959
72. E. Campalani, and C.A. Holden Keratoacanthoma associated with the use of topical imiquimod Clin Exp Dermatol 38 2013 555 556
73. A.M. Pini, S. Koch, L. Scharer, L.E. French, S. Lauchli, and G.F. Hofbauer Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient J Am Acad Dermatol 59 Suppl 2008 S116 S117
74. R. Gogia, R.C. Grekin, and K. Shinkai Eruptive self-resolving keratoacanthomas developing after treatment with photodynamic therapy and microdermabrasion Dermatol Surg 39 2013 1717 1720
75. I. Zalaudek, J. Giacomel, K. Schmid, and et al. Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model J Am Acad Dermatol 66 2012 589 597
76. C. Rosendahl, A. Cameron, G. Argenziano, I. Zalaudek, P. Tschandl, and H. Kittler Dermoscopy of squamous cell carcinoma and keratoacanthoma Arch Dermatol 148 2012 1386 1392
77. S. Cavicchini, A. Tourlaki, L. Lunardon, V. Boneschi, and R. Gianotti Amelanotic melanoma mimicking keratoacanthoma: the diagnostic role of dermoscopy Int J Dermatol 52 2013 1023 1024
78. M. Dabska, and A. Madejczykowa Rogowiak kolczastokomorkowy: keratoacanthoma (molluscum sebaceum, molluscum pseudocarcino- matosum). Studium patologiczno-kliniczne Nowotwory 9 1959 1 23
79. M. Dabska Keratoacanthoma [in Polish] Wiad Lek 18 1965 1249 1250
80. W.H. Kern, and M.K. McCray The histopathologic differentiation of keratoacanthoma and squamous cell carcinoma of the skin J Cutan Pathol 7 1980 318 325
81. O. Sagol, B. Kurtoglu, E. Ozer, and U. Pabuccuoglu Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas Gen Diagn Pathol 143 1998 305 309
82. P. Phillips, and K.F. Helm Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma J Cutan Pathol 20 1993 424 428
83. G.L. Ellis Differentiating keratoacanthoma from squamous cell carcinoma of the lower lip: an analysis of intraepithelial elastic fibers and intracytoplasmic glycogen Oral Surg Oral Med Oral Pathol 56 1983 527 532
84. M. Binder, A. Steiner, U. Mossbacher, M. Hunegnaw, H. Pehamberger, and K. Wolff Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma Am J Dermatopathol 20 1998 453 458
85. P.P. Aung, L.Y. Ballester, and M. Mahalingam Histopathology of keratoacanthoma revisited: utility of orificial size as a diagnostic adjunct Int J Surg Pathol 22 2013 316 325
86. J. Kwittken A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma) M Sinai J Med 42 1975 127 135
87. B. Milewski, and T. Chorzelski Comparative histological and histochemical studies on keratoacanthoma and highly differentiated spinocellular epithelioma [in German] Hautarzt 13 1962 7 12
88. B. Cribier, P. Asch, and E. Grosshans Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases Dermatology 199 1999 208 212
89. P.H. Asch, P. Basset, M. Roos, E. Grosshans, J.P. Bellocq, and B. Cribier Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma Am J Dermatopathol 21 1999 146 150
90. G. Kannon, and H.K. Park Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma Am J Dermatopathol 12 1990 31 36
91. D.D. Weedon, J. Malo, D. Brooks, and R. Williamson Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly Am J Dermatopathol 32 2010 423 426
92. E. Sanchez Yus, P. Simon, L. Requena, P. Ambrojo, and E. de Eusebio Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant Am J Dermatopathol 22 2000 305 310
93. T. Tsuji Keratoacanthoma and squamous cell carcinoma: study of PCNA and Le(Y) expression J Cutan Pathol 24 1997 409 415
94. K. Peris, F. Magrini, G. Keller, and et al. Analysis of microsatellite instability and loss of heterozygosity in keratoacanthoma Arch Dermatol Res 289 1997 185 188
95. D. Yao, C.L. Alexander, J.A. Quinn, W.C. Chan, H. Wu, and D.A. Greenhalgh Fos cooperation with PTEN loss elicits keratoacanthoma not carcinoma, owing to p53/p21 WAF-induced differentiation triggered by GSK3beta inactivation and reduced AKT activity J Cell Sci 121 2008 1758 1769
96. N. Vasiljevic, K. Andersson, K. Bjelkenkrantz, and et al. The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma Int J Cancer 124 2009 2361 2366
97. T.J. Stephenson, J.A. Royds, S.S. Bleehen, P.B. Silcocks, and R.C. Rees 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma Dermatology 187 1993 95 99
98. T.J. Stephenson, J. Royds, P.B. Silcocks, and S.S. Bleehen Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma Br J Dermatol 127 1992 566 570
99. T.C. Putti, M. Teh, and Y.S. Lee Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers Mod Pathol 17 2004 468 475
100. W.S. Lowry, and R.J. Atkinson Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma Br J Dermatol 128 1993 708
101. Y.S. Lee, and M. Teh p53 Expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin Cancer 73 1994 2317 2323
102. P.E. LeBoit Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy... soon? Am J Dermatopathol 17 1995 319 320
103. R.L. Kerschmann, T.H. McCalmont, and P.E. LeBoit p53 Oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma Arch Dermatol 130 1994 181 186
104. M. Connolly, S. Narayan, J. Oxley, and D.A. de Berker Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma Clin Exp Dermatol 33 2008 625 628
105. C.T. Cain, T.H. Niemann, and Z.B. Argenyi Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors Am J Dermatopathol 17 1995 324 331
106. T. Batinac, G. Zamolo, M. Coklo, I. Hadzisejdic, C. Stemberger, and G. Zauhar Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma Pathol Res Pract 202 2006 599 607
107. D. Cabibi, F. Aragona, C. Guarnotta, and et al. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients Appl Immunohistochem Mol Morphol 19 2011 239 245
108. M. Fujii, M. Honma, H. Takahashi, A. Ishida-Yamamoto, and H. Iizuka The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma Clin Exp Dermatol 36 2011 788 792
109. L. Cabrijan, J. Lipozencic, T. Batinac, M. Lenkovic, and Z.S. Zgombic Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha Coll Antropol 37 2013 147 150
110. A.J. Waring, M. Takata, I. Rehman, and J.L. Rees Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma Br J Cancer 73 1996 649 653
111. S. Biesterfeld, and J. Josef Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry Anticancer Res 22 2002 3019 3023
112. A. Patel, G.M. Halliday, B.E. Cooke, and R.S. Barnetson Evidence that regression in keratoacanthoma is immunologically mediated: a comparison with squamous cell carcinoma Br J Dermatol 131 1994 789 798
113. N.D. Melendez, B.R. Smoller, and M.V.C.A.M. Morgan (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas Mod Pathol 16 2003 8 13
114. T.A. Tran, J.S. Ross, J.R. Boehm, and J.A. Carlson Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma J Cutan Pathol 26 1999 391 397
115. H. Takeda, and S. Kondo Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression Am J Pathol 158 2001 1633 1637
116. P. Mukunyadzi, R.D. Sanderson, C.Y. Fan, and B.R. Smoller The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma Mod Pathol 15 2002 45 49
117. A.M. Godbolt, J.J. Sullivan, and D. Weedon Keratoacanthoma with perineural invasion: a report of 40 cases Australas J Dermatol 42 2001 168 171
118. N.A. Lapins, and E.B. Helwig Perineural invasion by keratoacanthoma Arch Dermatol 116 1980 791 793
119. Y. Basoglu, D. Metze, D. Nashan, and S. Stander Keratoacanthoma with perineural invasion: an indicator for aggressive behavior? J Dtsch Dermatol Ges 6 2008 952 955
120. O. Abbas, L. Hussein, M. Kurban, and A.G. Kibbi Plasmacytoid dendritic cell involvement in the host response against keratoacanthoma J Am Acad Dermatol 70 2014 1142 1145
121. K. Zduniak, S. Agrawal, K. Symonowicz, K. Jurczyszyn, and P. Ziolkowski The comparison of nuclear ubiquitous casein and cyclin-dependent kinases substrate (NUCKS) with Ki67 proliferation marker expression in common skin tumors Pol J Pathol 65 2014 48 54
122. M. Slater, and J.A. Barden Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers Histopathology 47 2005 170 178
123. A.L. Krunic, D.R. Garrod, S. Madani, M.D. Buchanan, and R.E. Clark Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin Br J Cancer 77 1998 1275 1279
124. T.A. Tran, J.S. Ross, C.E. Sheehan, and J.A. Carlson Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma Mod Pathol 13 2000 427 432
125. S. Soddu, E. Di Felice, S. Cabras, and et al. IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study Eur J Histochem 57 2013 e6
126. A.J. Klein-Szanto, R.J. Barr, J.J. Reiners Jr.; and M.D. Mamrack Filaggrin distribution in keratoacanthomas and squamous cell carcinoma Arch Pathol Lab Med 108 1984 888 890
127. E. Ichikawa, T. Ohnishi, and S. Watanabe Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis J Dermatol Sci 34 2004 115 117
128. L. LaPresto, L. Cranmer, L. Morrison, C.P. Erickson, and C. Curiel-Lewandrowski A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil JAMA Dermatol 149 2013 279 281
129. A. Reich, M. Kobierzycka, Z. Wozniak, M. Cislo, and J.C. Szepietowski Keratoacanthoma-like cutaneous metastasis of lung cancer: a learning point Acta Derm Venereol 86 2006 459 460
130. J.A. Aramburu-Gonzalez, M. Rodriguez-Justo, J. Jimenez-Reyes, and C. Santonja A case of soft tissue mesenchymal chondrosarcoma metastatic to skin, clinically mimicking keratoacanthoma Am J Dermatopathol 21 1999 392 394
131. D.S. Cassarino, W. Xue, and K.J. Shannon Widespread cutaneous and perioral metastases of mesothelioma J Cutan Pathol 30 2003 582 585
132. J.H. Lin, and J.Y. Lee Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia J Cutan Pathol 31 2004 458 461
133. S. Kaddu, H.P. Soyer, L. Cerroni, W. Salmhofer, and S. Hodl Clinical and histopathologic spectrum of pilomatricomas in adults Int J Dermatol 33 1994 705 708
134. J.J. Meffert Cutaneous sporotrichosis presenting as a keratoacanthoma Cutis 62 1998 37 39
135. F. Lauermann, M. Lyra, and R. Gaudio Sporotrichosis mimicking keratoacanthoma Am J Trop Med Hyg 86 2012 741
136. L. Miteva, V. Broshtilova, and R.A. Schwartz Verrucous systemic lupus erythematosus Acta Dermatovenerol Croat 17 2009 301 304
137. N. Misago, T. Inoue, S. Koba, and Y. Narisawa Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification J Dermatol 40 2013 443 452
138. A.E. Kallibjian, and J.N. Choos Keratoacanthoma or verrucous carcinoma? A case report J Foot Ankle Surg 32 1993 584 590
139. I. Shendrik, A.N. Crowson, and C.M. Magro Follicular cutaneous squamous cell carcinoma: an under-recognized neoplasm arising from hair appendage structures Br J Dermatol 169 2013 384 388
140. R.A. Carr, S.M. Taibjee, N. Turnbull, and S. Attili Follicular squamous cell carcinoma is an under-recognized common skin tumor Diagn Histopathol 20 2014 289 296
141. R.W. Griffiths Keratoacanthoma observed Br J Plast Surg 57 2004 485 501
142. F. Piscioli, S. Boi, G. Zumiani, and M. Cristofolini A gigantic, metastasizing keratoacanthoma. Report of a case and discussion on classification Am J Dermatopathol 6 1984 123 129
143. B.A. Davis, G.D. Monheit, and L. Kline Metastatic skin cancer presenting as ptosis and diplopia Dermatol Surg 32 2006 148 158
144. E. Hodak, R.E. Jones, and A.B. Ackerman Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases Am J Dermatopathol 15 1993 332 352
145. J.A. Savage, and J.C. Maize Sr. Keratoacanthoma clinical behavior: a systematic review Am J Dermatopathol 36 2014 422 429
146. M.C. Weinstein, R.T. Brodell, J. Bordeaux, and K. Honda The art and science of surgical margins for the dermatopathologist Am J Dermatopathol 34 2012 737 745
147. C.R. Rogers, and M.L. Bentz An evidence-based approach to the treatment of nonmelanoma facial skin malignancies Plast Reconstr Surg 127 2011 940 948
148. A.E. Schell, M.A. Russell, and S.S. Park Suggested excisional margins for cutaneous malignant lesions based on Mohs micrographic surgery JAMA Facial Plast Surg 15 2013 337 343
149. J.E. Jackson, B. Kelly, M. Petitt, T. Uchida, and R.F. Wagner Jr. Predictive value of margins in diagnostic biopsies of nonmelanoma skin cancers J Am Acad Dermatol 67 2012 122 127
150. L. Benest, R.P. Kaplan, R. Salit, and R. Moy Keratoacanthoma centrifugum marginatum of the lower extremity treated with Mohs micrographic surgery J Am Acad Dermatol 31 1994 501 502
151. E. Klein, F. Helm, H. Milgrom, H.L. Stoll Jr.; and H.L. Traenkle Tumors of the skin. II. Keratoacanthoma; local effect of 5-fluorouracil Skin 1 1962 153 156
152. J.S. Kirby, and C.J. Miller Intralesional chemotherapy for nonmelanoma skin cancer: a practical review J Am Acad Dermatol 63 2010 689 702
153. N.M. Annest, M.J. VanBeek, C.J. Arpey, and D.C. Whitaker Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature J Am Acad Dermatol 56 2007 989 993
154. N. Aubut, J. Alain, and J. Claveau Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series J Cutan Med Surg 16 2012 212 217
155. A. Martorell-Calatayud, C. Requena, E. Nagore, and et al. Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial [in Spanish] Actas Dermosifiliogr 102 2011 605 615
156. J.H. Yeon, J.Y. Jung, J.W. Choi, and et al. Keratoacanthoma aggravated after photodynamic therapy J Dermatol 37 2010 765 766
157. E. Maydan, P.K. Nootheti, and M.P. Goldman Development of a keratoacanthoma after topical photodynamic therapy with 5-aminolevulinic acid J Drugs Dermatol 5 2006 804 806
158. J.J. Thiele, M. Ziemer, S. Fuchs, and P. Elsner Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg Dermatol Surg 30 2004 1556 1560
159. M. Chaffai, M.H. Houman, and S. Haouet Ben Osman A. Keratoacanthoma centrifugum marginatum [in French] Ann Dermatol Venereol 121 1994 731 733
160. M.T. V'Lckova-Laskoska, and D.S. Laskoski Keratoacanthoma centrifugum marginatum: a rare atypical variant of keratoacanthoma Clin Exp Dermatol 33 2008 259 261
161. T.K. Bulj, A.L. Krunic, A.S. Cetner, and J.L. Villano Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib Br J Dermatol 163 2010 633 637
162. M.M. Farias, A. Hasson, C. Navarrete, C. Nicklas, I. Garcia-Huidobro, and S. Gonzalez Efficacy of topical photodynamic therapy for keratoacanthomas: a case-series of four patients Indian J Dermatology Venereol Leprol 78 2012 172 174
163. M. Caccialanza, and N. Sopelana Radiation therapy of keratoacanthomas: results in 55 patients Int J Radiat Oncol Biol Phys 16 1989 475 477
164. V.A. Cipollaro The use of podophyllin in the treatment of keratoacanthoma Int J Dermatol 22 1983 436 440
165. Z. Starzycki Use of Ufudix ointment for the treatment of keratoacanthoma. I. Clinical evaluation of the results [in Polish] Przegl Dermatol 67 1980 469 474
166. H.C. Jeon, M. Choi, S.H. Paik, C.H. Ahn, H.S. Park, and K.H. Cho Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report Ann Dermatol 23 2011 357 361
167. M. Kaźmierowski, and M. Bowszyc-Dmochowska Multiple keratoacanthomas treated with cryosurgery and retinoids Postepy Dermatol (Poznan) 14 1997 397 402
168. M.L. Street, J.W. White Jr.; and L.E. Gibson Multiple keratoacanthomas treated with oral retinoids J Am Acad Dermatol 23 1990 862 866
169. A. Nofal, M. Assaf, S. Ghonemy, E. Nofal, and A. Yosef Generalized eruptive keratoacanthoma: a diagnostic and therapeutic challenge Int J Dermatol 54 2015 160 167
170. D.C. Reid, J. Guitart, M. Agulnik, and M.E. Lacouture Treatment of multiple keratoacanthomas with erlotinib Int J Clin Oncol 15 2010 413 415
171. S. Sanders, K.J. Busam, A.C. Halpern, and K.S. Nehal Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy Dermatol Surg 28 2002 954 958
172. A. Alloo, L. Garibyan, N. LeBoeuf, and et al. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma Arch Dermatol 148 2012 363 366
173. D. Stevanović, and A. Krunić Keratoacanthoma: a dangerous trap E. Panconesi, Dermatology in Europe Proceedings of the First Congress of the European Academy of Dermatology and Venereology, Florence, Italy September 25-28, 1989 1991 Blackwell Scientific Oxford 390 392
174. H.E. Grossniklaus, T.H. Wojno, M. Yanoff, and R.L. Font Invasive keratoacanthoma of the eyelid and ocular adnexa Ophthalmology 103 1996 937 941
175. R.A. Schwartz Keratoacanthoma: an abortive squamous cell carcinoma that does not always fail G Ital Dermatol Venereol 138 2003 355 362